Journey Medical Stock (NASDAQ: DERM) stock price, news, charts, stock research, profile.
Open | $3.490 |
Close | $3.400 |
Volume / Avg. | 64.845K / 168.701K |
Day Range | 3.360 - 3.540 |
52 Wk Range | 1.020 - 8.110 |
Market Cap | $71.756M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.43% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Journey Medical (NASDAQ: DERM) through any online brokerage.
Other companies in Journey Medical’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
The latest price target for Journey Medical (NASDAQ: DERM) was reported by Alliance Global Partners on Friday, February 16, 2024. The analyst firm set a price target for 8.50 expecting DERM to rise to within 12 months (a possible 136.11% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Journey Medical (NASDAQ: DERM) is $3.6 last updated April 25, 2024 at 5:35 PM EDT.
There are no upcoming dividends for Journey Medical.
Journey Medical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Journey Medical.
Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.